ResearchSafe

Serrapeptase (Serrapeptase (Serratiopeptidase))

Category: Cardiovascular. Status: Dietary supplement.

A proteolytic enzyme originally isolated from Serratia bacteria in silkworm intestines. Used for its anti-inflammatory, fibrinolytic, and mucolytic properties. Popular for arterial plaque reduction and post-surgical swelling.

How it works

Degrades non-living tissue including fibrin, blood clots, mucus, and arterial plaque without harming living cells. Inhibits bradykinin release and reduces prostaglandin synthesis for anti-inflammatory effects.

Key facts

  • Molecular weight: ~52,000 Da
  • Half-life: ~4-6 hours
  • Bioavailability: Oral (enteric-coated required); detectable in bloodstream
  • Storage: Room temperature. Keep dry.

Dosing overview

  • Typical dose: 120,000-240,000 SPU
  • Frequency: Daily on empty stomach
  • Duration: Ongoing or 8-12 week cycles
  • Route: Oral (enteric-coated)

Reported benefits

  • Reduced inflammation and swelling
  • Arterial plaque modulation
  • Mucus/biofilm breakdown
  • Post-surgical recovery
  • Sinus/respiratory clearing
  • Pain reduction

Possible side effects

  • Nausea (if taken with food)
  • Rare: skin rash
  • Potential bleeding risk
  • GI discomfort

Research

  • Serrapeptase and post-operative swelling (2020): Reduced post-surgical edema by 50% and pain scores by 40% vs placebo in dental and orthopedic procedures.
  • Serrapeptase and arterial plaque (2021): Animal models showed 30% reduction in atherosclerotic plaque burden over 12 weeks with no adverse effects on healthy tissue.

Compare Serrapeptase

Community discussions about Serrapeptase

Research and educational reference only. Not medical advice.